Dr. Paul A.s. Fishkin, MD

Dr. Fishkin practices at Oncology-Hematology Associates of Central Illinois P C in Peoria, Illinois.

Dr. Fishkin's NPI, 1063411379, was assigned on July 19, 2005. Dr. Fishkin graduated from Creighton University School of Medicine - Omaha in 1984. Dr. Fishkin holds Illinois license 036-087874.

Dr. Fishkin's primary practice is Oncology-Hematology Associates of Central Illinois P C, at 8940 N Wood Sage Rd, Peoria, IL 61615 in Peoria County. The practice phone is (309) 243-3000.

Dr. Fishkin's primary practice is Oncology-Hematology Associates of Central Illinois P C in Peoria, Illinois. Dr. Fishkin is also affiliated with OSF Saint Francis Medical Center. The medical group on file is Illinois CancerCare. Dmand AI also links Dr. Fishkin to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fishkin practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fishkin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fishkin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Fishkin's licenses on file in 4 states: Illinois, California, Hawaii and Oklahoma.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Fishkin treats.

CMS data shows 185,541 Medicare services from Dr. Fishkin across 74 procedure codes in 2024, for 1,276 Medicare patients. Medicare paid $1,604,207 for them. Every service was in an office.

CMS counts 1,276 Medicare patients who saw Dr. Fishkin in 2024. The largest group is 65 to 74, with 537 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fishkin's median patient age at 70, with 56% women.

In 2024, Dr. Fishkin wrote 2,988 Medicare Part D claims for 406 patients. 77% of them were for generic drugs. CMS names the drug for 2,572 of them, across 50 drugs with 11 or more claims each, at $5,149,872 in total drug cost. In 2023, CMS named 2,530 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Fishkin for performance year 2024, reported as part of a group. Dr. Fishkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fishkin as offering telehealth.

Dmand AI links 24 papers to Dr. Fishkin, published from 2010 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Breast Neoplasms. Dr. Fishkin has published most often in J Clin Oncol. Dr. Fishkin's most frequent co-authors are Edith Perez, MD, Philip C. Hoffman and David J. Inwards, MD.

Dmand AI links Dr. Fishkin to 5 clinical trials, 3 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Intraocular Lymphoma, Melanoma and Pancreatic Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 38 general payments to Dr. Fishkin from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Abbvie Inc. paid the most, $3,918.

Dmand AI lists 1 award for Dr. Fishkin, most recently CMS Stage 1 EHR in 2013.

Dr. Fishkin graduated from Creighton University School of Medicine - Omaha in 1984. Dr. Fishkin is a member of ACP, ASCO and ASH.

Dr. Fishkin is in network with 18 carriers, including Aetna, Elevance and HCSC. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.